Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Pulmonx Corp LUNG

Healthcare Medical Devices
Pulmonx Corporation is a commercial-stage medical technology company. The Company provides minimally invasive treatments for chronic obstructive pulmonary disease (COPD). The Company’s Zephyr Endobronchial Valve, Chartis Pulmonary Assessment System, LungTraX Platform, and StratX Lung Analysis Report are designed to assess and treat patients with severe emphysema/COPD. The LungTraX Platform is a... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LUNG)

Pulmonx Reports Record Fourth Quarter and Full Year 2024 Financial Results

GlobeNewswire February 19, 2025

Pulmonx to Present at the Citi 2025 Unplugged Medtech and Life Sciences Access Day

GlobeNewswire February 13, 2025

Pulmonx to Report Fourth Quarter and Full Year 2024 Financial Results on February 19, 2025

GlobeNewswire February 5, 2025

Pulmonx to Present at the Piper Sandler 36th Annual Healthcare Conference

GlobeNewswire November 20, 2024

Pulmonx Partners with American Lung Association to Launch New Educational Initiatives for COPD Patients and Providers

Business Wire November 19, 2024

Pulmonx to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

GlobeNewswire November 7, 2024

Pulmonx to Present at the Stifel 2024 Healthcare Conference

GlobeNewswire November 5, 2024

Pulmonx Reports Third Quarter 2024 Financial Results

GlobeNewswire October 30, 2024

Pulmonx to Report Third Quarter 2024 Financial Results on October 30, 2024

GlobeNewswire October 16, 2024
View More News ››

Opinion & Analysis (NDAQ:LUNG)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LUNG)

Using technical analysis for this one.

This stock was a good buy for me in the pre market action this morning and it is going up
coolfooldumbguy - February 20, 2025

PULMONX: BREATH OF FRESH AIR FOR LUNG DISEASE PATIENTS

$LUNG Excited to share an article about Pulmonx Corp (NASDAQ: LUNG), a global leader in minimally invasive treatments...
AviseAnalytics - June 27, 2023
View more Bullboard ››

Tribe Property Technologies Inc.

Tribe Property Technologies Inc.

Tribe Property Technologies Inc. is a property technology company. The Company offers technology-enabled property management ...
View More »